Literature DB >> 16741711

Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision.

Ute Mathis1, Frank Schaeffel.   

Abstract

BACKGROUND: In chickens, retinal glucagon amacrine cells play an important role in emmetropization, since they express the transcription factor ZENK (also known as NGFI-A, zif268, tis8, cef5, Krox24) in correlation with the sign of imposed image defocus. Pharmacological studies have shown that glucagon can act as a stop signal for axial eye growth, making it a promising target for pharmacological intervention of myopia. Unfortunately, in mammalian retina, glucagon itself has not yet been detected by immunohistochemical staining. To learn more about its possible role in emmetropization in mammals, we studied the expression of different members of the glucagon hormone family in mouse retina, and whether their abundance is regulated by visual experience.
METHODS: Black wildtype C57BL/6 mice, raised under a 12/12 h light/dark cycle, were studied at postnatal ages between P29 and P40. Frosted hemispherical thin plastic shells (diffusers) were placed in front of the right eyes to impose visual conditions that are known to induce myopia. The left eyes remained uncovered and served as controls. Transversal retinal cryostat sections were single- or double-labeled by indirect immunofluorescence for early growth response protein 1 (Egr-1, the mammalian ortholog of ZENK), glucagon, glucagon-like peptide-2 (GLP-2), glucose-dependent insulinotropic polypeptide (GIP), peptide histidine isoleucine (PHI), growth hormone-releasing hormone (GHRH), pituitary adenylate cyclase-activating polypeptide (PACAP), secretin, and vasoactive intestinal polypeptide (VIP). In total, retinas of 45 mice were studied, 28 treated with diffusers, and 17 serving as controls.
RESULTS: Glucagon itself was not detected in mouse retina. VIP, PHI, PACAP and GIP were localized. VIP was co-localized with PHI and Egr-1, which itself was strongly regulated by retinal illumination. Diffusers, applied for various durations (1, 2, 6, and 24 h) had no effect on the expression of VIP, PHI, PACAP, and GIP, at least at the protein level. Similarly, even if the analysis was confined to cells that also expressed Egr-1, no difference was found between VIP expression in eyes with diffusers and in eyes with normal vision.
CONCLUSIONS: Several members of the glucagon super family are expressed in mouse retina (although not glucagon itself), but their expression pattern does not seem to be regulated by visual experience.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16741711     DOI: 10.1007/s00417-006-0282-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  39 in total

1.  Defocus-induced changes in ZENK expression in the chicken retina.

Authors:  Michaela Bitzer; Frank Schaeffel
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

2.  Effects of different concentrations of atropine on controlling myopia in myopic children.

Authors:  Y F Shih; C H Chen; A C Chou; T C Ho; L L Lin; P T Hung
Journal:  J Ocul Pharmacol Ther       Date:  1999-02       Impact factor: 2.671

3.  Darkness and myopia progression.

Authors:  Karla Zadnik; Donald O Mutti
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

4.  Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study.

Authors:  R Michael Siatkowski; Susan Cotter; Joseph M Miller; Colin A Scher; R Stephens Crockett; Gary D Novack
Journal:  Arch Ophthalmol       Date:  2004-11

5.  Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism.

Authors:  Hue-Trung Truong; Charles L Cottriall; Alex Gentle; Neville A McBrien
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

6.  Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells.

Authors:  Alessandro Cellerino; Blanca Arango-González; Germán Pinzón-Duarte; Konrad Kohler
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

7.  Somatostatin and VIP neurons in the retina of different species.

Authors:  K Tornqvist; R Uddman; F Sundler; B Ehinger
Journal:  Histochemistry       Date:  1982

8.  Measurement of refractive state and deprivation myopia in two strains of mice.

Authors:  Frank Schaeffel; Eva Burkhardt; Howard C Howland; Robert W Williams
Journal:  Optom Vis Sci       Date:  2004-02       Impact factor: 1.973

9.  Distribution and ultrastructural localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor in the rat retina.

Authors:  T Seki; S Shioda; Y Nakai; A Arimura; R Koide
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

10.  A peptide histidine isoleucine/peptide histidine methionine-like peptide in the rabbit retina: colocalization with vasoactive intestinal peptide, synaptic relationships and activation of adenylate cyclase activity.

Authors:  J A Pachter; D W Marshak; D M Lam; K R Fry
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

View more
  17 in total

1.  The hyperopic effect of narrow-band long-wavelength light in tree shrews increases non-linearly with duration.

Authors:  Alexander H Ward; Thomas T Norton; Carrie E Huisingh; Timothy J Gawne
Journal:  Vision Res       Date:  2018-04-26       Impact factor: 1.886

Review 2.  The chick eye in vision research: An excellent model for the study of ocular disease.

Authors:  C Ellis Wisely; Javed A Sayed; Heather Tamez; Chris Zelinka; Mohamed H Abdel-Rahman; Andy J Fischer; Colleen M Cebulla
Journal:  Prog Retin Eye Res       Date:  2017-06-28       Impact factor: 21.198

Review 3.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

4.  Vasoactive intestinal peptide, a promising agent for myopia?

Authors:  Ayse Idil Cakmak; Hikmet Basmak; Huseyin Gursoy; Mete Ozkurt; Nilgun Yildirim; Nilufer Erkasap; Mustafa Deger Bilgec; Nese Tuncel; Ertugrul Colak
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

5.  Opposite effects of glucagon and insulin on compensation for spectacle lenses in chicks.

Authors:  Xiaoying Zhu; Josh Wallman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

Review 6.  Circadian rhythms, refractive development, and myopia.

Authors:  Ranjay Chakraborty; Lisa A Ostrin; Debora L Nickla; P Michael Iuvone; Machelle T Pardue; Richard A Stone
Journal:  Ophthalmic Physiol Opt       Date:  2018-05       Impact factor: 3.117

Review 7.  Investigating mechanisms of myopia in mice.

Authors:  Machelle T Pardue; Richard A Stone; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2013-01-07       Impact factor: 3.467

Review 8.  Pharmacogenomic Approach to Antimyopia Drug Development: Pathways Lead the Way.

Authors:  Tatiana V Tkatchenko; Andrei V Tkatchenko
Journal:  Trends Pharmacol Sci       Date:  2019-10-30       Impact factor: 14.819

9.  Genome-wide analysis of retinal transcriptome reveals common genetic network underlying perception of contrast and optical defocus detection.

Authors:  Tatiana V Tkatchenko; Andrei V Tkatchenko
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063

10.  Insulin-like growth factor 1 is not associated with high myopia in a large Japanese cohort.

Authors:  Masahiro Miyake; Kenji Yamashiro; Hideo Nakanishi; Isao Nakata; Yumiko Akagi-Kurashige; Akitaka Tsujikawa; Muka Moriyama; Kyoko Ohno-Matsui; Manabu Mochizuki; Ryo Yamada; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Mol Vis       Date:  2013-05-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.